• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Second Sight

Second Sight facing Nasdaq delisting

October 5, 2020 By Sean Whooley

Second Sight Medical (NSDQ:EYES) announced that it received a letter from the Nasdaq market confirming that it may face delisting. The Sylmar, Calif.-based developer and manufacturer of implantable visual prosthetics for blind individuals received the letter confirming that its common stock had closed below the $1 per share minimum required for continued listing for 30 consecutive […]

Filed Under: Business/Financial News, Optical/Ophthalmic, Wall Street Beat Tagged With: NASDAQ, Second Sight

Second Sight Medical schedules auction of its assets

June 16, 2020 By Nancy Crotti

The assets of Second Sight Medical (NSDQ:EYES) are going up for auction on June 25. The developer and manufacturer of implantable visual prosthetics for blind individuals created the only FDA-approved implantable visual prosthetic treatment for severe retinitis pigmentosa. The company said in March that it was winding down its operations amid the financial shock of the COVID-19 pandemic. […]

Filed Under: Business/Financial News, Featured, Vision, Wall Street Beat Tagged With: Second Sight

Second Sight closes $6.8m offering

May 7, 2020 By Sean Whooley

Second Sight Medical (NSDQ:EYES) announced that it closed an offering of its common stock worth approximately $6.8 million. The maker of visual prosthetic implants for blind individuals priced the offering of 7.5 million common stock shares at $1 per share last week, with Fordham Financial Management’s ThinkEquity division acting as a representative of the underwriters in […]

Filed Under: Business/Financial News, Funding Roundup, Optical/Ophthalmic Tagged With: Second Sight

Second Sight prices public offering

May 1, 2020 By Sean Whooley

Second Sight Medical (NSDQ:EYES) announced that it priced an underwritten public offering with expected gross proceeds reaching $7.5 million. The maker of visual prosthetic implants for blind individuals announced in March that it was winding down its operations amid the financial shock of the COVID-19 pandemic. At the time, the company said it would lay off […]

Filed Under: Business/Financial News, Funding Roundup, Implants, Optical/Ophthalmic Tagged With: Second Sight

Second Sight Medical assessing business options following mass layoffs

April 28, 2020 By Sean Whooley

Second Sight Medical (NSDQ:EYES) announced today that it took steps to reduce overhead and conserve liquidity ahead of potential partnering, acquiring, or combining with businesses. The maker of visual prosthetic implants for blind individuals announced last month that it was winding down its operations amid the financial shock of the coronavirus pandemic. At the time, Second […]

Filed Under: Business/Financial News, Neuromodulation/Neurostimulation, Optical/Ophthalmic Tagged With: Second Sight

BREAKING: Second Sight Medical laying off most of its workers, winding down

March 30, 2020 By Chris Newmarker

Second Sight Medical (NSDQ:EYES) announced today that it will wind down its operations amid the financial shock of the coronavirus pandemic. The Los Angeles–based company will lay off 84 of its 108 employees and will retain an adviser experienced in winding down operations to guide the board on the next steps. Company officials expect additional layoffs. […]

Filed Under: Business/Financial News, Featured, Neuromodulation/Neurostimulation, News Well, Optical/Ophthalmic, Wall Street Beat Tagged With: coronavirus, Second Sight

Second Sight device restores visual perception in blind

September 27, 2019 By Danielle Kirsh

Researchers at UCLA Health have surgically implanted blind patients with the Second Sight Orion device to improve their visual perception. The Orion device is designed to boost the ability to navigate by restoring their ability to perceive objects and movement. The device converts images captured by a tiny video camera on top of sunglasses into […]

Filed Under: Implants, Optical/Ophthalmic, Vision Tagged With: Second Sight, UCLA Health

Biomet vet Serbousek to succeed Mason as Orthofix CEO | Personnel Moves, August 13, 2019

August 13, 2019 By Brad Perriello

Orthofix (NSDQ:OFIX) last week named a successor for president & CEO Brad Mason in November, tapping Jon Serbousek as president of its spine business effective August 5. Mason is slated to retire Oct. 31; Serbousek, a 30-year medtech veteran with stints at Biomet, Medtronic (NYSE:MDT) and Johnson & Johnson (NYSE:JNJ) unit DePuy Orthopaedics, is due to […]

Filed Under: Business/Financial News, Featured Tagged With: Accuray Inc., Bill & Melinda Gates Foundation, CeloNova BioSciences, Corinth MedTech, MiMedx Group Inc., Nimbus Concepts, On Target Labs, Orthofix, Personnel Moves, Ra Medical, ReShape Lifesciences, Second Sight, Stryker, Virginia Bio

Second Sight beat The Street in Q2 despite $8.44m loss

August 7, 2019 By Nancy Crotti

Second Sight Medical (NSDQ:EYES) posted second-quarter results yesterday that beat both the sales and earnings forecasts on Wall Street as it accelerated its pivot toward manufacturing a new cortical implant. Citing the costs of reorganization, the Sylmar, Calif.-based company reported a  loss of $8.44 million, or -0.07¢ per share, on sales of $1.28 million for […]

Filed Under: Blog, Business/Financial News, Featured, Neuromodulation/Neurostimulation, News Well, Prosthetics, Research & Development, Vision, Wall Street Beat Tagged With: Second Sight

Second Sight accelerates Orion visual prosthesis dev, posts Q1 miss

May 16, 2019 By Fink Densford

Second Sight Medical (NSDQ:EYES) said yesterday that it plans to accelerate development and commercialization of its Orion visual cortical prosthesis system and posted first quarter earnings that missed expectations on Wall Street. Sylmar, Calif.-based Second Sight’s Orion is designed to connect the camera in a pair of eyeglasses with an implant that receives the camera signal […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Optical/Ophthalmic, Research & Development, Wall Street Beat Tagged With: Second Sight

Second Sight Medical releases early feasibility data on Orion cortical implant

April 11, 2019 By Brad Perriello

Second Sight Medical (NSDQ:EYES) today announced preliminary results from a small feasibility study of its Orion cortical implant, which is designed to give eyesight to the blind. Sylmar, Calif.-based Second Sight’s Orion is designed to connect the camera in a pair of eyeglasses with an implant that receives the camera signal and translates it to […]

Filed Under: Clinical Trials, Featured, Optical/Ophthalmic Tagged With: Second Sight

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS